Canakinumab Subcutaneous and Nexiclon XR
Determining the interaction of Canakinumab Subcutaneous and Nexiclon XR and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: clonidine
Brand name: Catapres, Catapres-TTS, Duraclon, Kapvay, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3
Synonyms: Nexiclon XR (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Nexiclon XR Suspension
- Canakinumab Subcutaneous-Nexium
- Canakinumab Subcutaneous-Nexium (Esomeprazole Delayed-Release Capsules)
- Canakinumab Subcutaneous-Nexium (Esomeprazole Powder for Suspension)
- Canakinumab Subcutaneous-Nexium 24HR (Esomeprazole Delayed-Release Capsules)
- Canakinumab Subcutaneous-NexIUM 24HR (Esomeprazole Delayed-Release Tablets)
- Nexiclon XR-Canasa
- Nexiclon XR-Canasa Pac rectal
- Nexiclon XR-Canasa rectal
- Nexiclon XR-Cancidas
- Nexiclon XR-Candesartan
- Nexiclon XR-Candesartan and Hydrochlorothiazide